vTv Therapeutics (VTVT) Accumulated Expenses (2014 - 2015)
vTv Therapeutics' (VTVT) quarterly Accumulated Expenses came in at $1.0 million in Q4 2015, up 11455.56% year-on-year from N/an in Q4 2014, and up 11455.56% quarter-over-quarter from $9000.0 in Q4 2014.
vTv Therapeutics (VTVT) Accumulated Expenses (2014 - 2015) Analysis & Trends
vTv Therapeutics has disclosed Accumulated Expenses across 2 years of filings, most recently posting $1.0 million for Q4 2015.
- Accumulated Expenses for Q4 2015 came in at $1.0 million, up 11455.56% year-over-year; the trailing twelve-month figure through Dec 2015 was $1.0 million (up 11455.56% YoY), and the FY2015 annual result was $1.0 million, up 11455.56% from the prior year.
- Accumulated Expenses came in at $1.0 million for Q4 2015 at vTv Therapeutics, up from $9000.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $1.0 million in Q4 2015 to a low of $9000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | vTv Therapeutics | 426.76 Mn | 426.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 1.04 Mn |
| Dec 31, 2014 | 9,000.00 |